key: cord-0961135-tgx8u9vj
authors: Bellato, Vittoria; Konishi, Tsuyoshi; Pellino, Gianluca; An, Yongbo; Piciocchi, Alfonso; Sensi, Bruno; Siragusa, Leandro; Khanna, Krishn; Pirozzi, Brunella Maria; Franceschilli, Marzia; Campanelli, Michela; Efetov, Sergey; Sica, Giuseppe S
title: Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices
date: 2020-08-11
journal: Journal of global health
DOI: 10.7189/jogh.10.020507
sha: 4523ff78b29791d132433aafc38890c73a48468d
doc_id: 961135
cord_uid: tgx8u9vj

BACKGROUND: In a surgical setting, COVID-19 patients may trigger in-hospital outbreaks and have worse postoperative outcomes. Despite these risks, there have been no consistent statements on surgical guidelines regarding the perioperative screening or management of COVID-19 patients, and we do not have objective global data that describe the current conditions surrounding this issue. This study aimed to clarify the current global surgical practice including COVID-19 screening, preventive measures and in-hospital infection under the COVID-19 pandemic, and to clarify the international gaps on infection control policies among countries worldwide. METHODS: During April 2-8, 2020, a cross-sectional online survey on surgical practice was distributed to surgeons worldwide through international surgical societies, social media and personal contacts. Main outcome and measures included preventive measures and screening policies of COVID-19 in surgical practice and centers’ experiences of in-hospital COVID-19 infection. Data were analyzed by country’s cumulative deaths number by April 8, 2020 (high risk, >5000; intermediate risk, 100-5000; low risk, <100). RESULTS: A total of 936 centers in 71 countries responded to the survey (high risk, 330 centers; intermediate risk, 242 centers; low risk, 364 centers). In the majority (71.9%) of the centers, local guidelines recommended preoperative testing based on symptoms or suspicious radiologic findings. Universal testing for every surgical patient was recommended in only 18.4% of the centers. In-hospital COVID-19 infection was reported from 31.5% of the centers, with higher rates in higher risk countries (high risk, 53.6%; intermediate risk, 26.4%; low risk, 14.8%; P < 0.001). Of the 295 centers that experienced in-hospital COVID-19 infection, 122 (41.4%) failed to trace it and 58 (19.7%) reported the infection originating from asymptomatic patients/staff members. Higher risk countries adopted more preventive measures including universal testing, routine testing of hospital staff and use of dedicated personal protective equipment in operation theatres, but there were remarkable discrepancies across the countries. CONCLUSIONS: This large international survey captured the global surgical practice under the COVID-19 pandemic and highlighted the insufficient preoperative screening of COVID-19 in the current surgical practice. More intensive screening programs will be necessary particularly in severely affected countries/institutions. STUDY REGISTRATION: Registered in ClinicalTrials.gov: NCT04344197

Your country Your city Name of your hospital Your center is? (type of hospital) Have any COVID-19 positive patients been admitted to your hospitals? (both medicine and surgery department, with number of caseloads)

To date, which kind of surgical procedures do you still perform at your hospital? How do you perform surgery? When is a surgical patient isolated in your center? Are you doing hospital team-rotations at your center? (e.g.: divide department staff member in two separated groups that works separately on rotation) When do you wear medical masks? Which of the following are easily available at your hospital?

If local guidelines are available at your center, which surgical patients do your local guidelines recommend testing? Do you perform a diagnostic Chest CT scan preoperatively to rule out When are hospital staff members tested at your hospital? Which type of test do you perform? How long does it take to get COVID-19 test results on average at your center? Have you experienced any in-hospital COVID-19 infections in your center? If yes, did you manage to trace the outbreak? Did any of your staff develop symptoms and test positive for COVID-19? If any hospital staff member is tested positive while being asymptomatic, they: VIEWPOINTS RESEARCH THEME 1:

COVID-19 PANDEMIC infections, and preventive measures and screening policies of COVID-19 in surgical practices. All questions were mandatory, and the participants were asked to provide profiles and names of the institutions to exclude duplicated registration.

The survey respondents were surgeons who represented the centers' surgical departments, and the individual surgeons were responsible for providing data on surgical practice at the centers. The centers in this study included academic hospitals, cancer centers and local public or private hospitals that were equipped with surgical departments. Survey participation was on a voluntary basis. In light of the rapidly changing situation in each country, we conducted the online survey within one week (April 2 to 8, 2020) . Google Forms (Google LLC, Menlo Park California, USA) was used to deliver the survey in 13 languages, and the Wenjuanxing platform (Changsha Ranxing Information Technology Co.,LTD, Hunan, China) was used to deliver a Chinese version in China. The survey was globally distributed to surgeons through emails, telephones, social media, and international surgical societies' social media platforms (European Society of Surgical Oncology, Latin American Society of Surgical Oncology, Russian Society of Colorectal Surgeons and Società Italiana di Chirurgia Colo-Rettale).

The study was approved by the institutional review board of Tor Vergata University of Rome (n.49/20) .

The study was registered on ClinicalTrials.gov (NCT04344197). Reporting of this study follows the American Association for Public Opinion Research reporting guideline and Checklist for Reporting Results of Internet E-Surveys [32] .

Data were analyzed by country's risk category. Countries were classified into high (>5000), intermediate (between 100 and 5000) and low (<100) risk groups based on the number of cumulative deaths reported by the WHO on April 8, 2020 (Figure 1 ). These death thresholds were defined by the fact that the most severely affected countries reached over 5000 deaths, and most countries started lockdown when the deaths exceeded 100 [33] . Data from countries with ≥25 centers were separately analyzed. Data were also analyzed by the centers' COVID-19 caseloads (>100, 50-100, 10-50, 1-10 and none). Only one representative respondent per center was included in the analyses, and duplicated registration from the same centers was manually excluded based on the provided profiles and names of the institutions. Comparison of the data was performed using the χ 2 and Fisher exact tests for categorical variables and the t test for continuous variables. Two-sided P values <0.05 were considered statistically significant. Analyses were performed by a statistician (AP) using R software (R Core Team (2019). R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria). (24), Portugal (17), Romania (13) , Austria (12) , Germany, India, Ireland (10), Belgium (8), Brazil, Switzerland (5), Canada, Sweden (4), South Korea (3), Indonesia (2), Denmark, Iran, and Poland (1) . Other countries in low risk (n = 115): Ukraina (11) , Azerbaijan (9), Pakistan (8), Egypt, Israel (6), Greece, Lithuania, Norway (5) VIEWPOINTS RESEARCH THEME 1: 

Results of current surgical procedures and protective measures by countries' risk group, country, and centers' COVID-19 caseloads are summarized in Table 2 , Table 3 and Table 4 . Overall, the majority of the centers performed emergency surgery (92.2%) and oncologic elective surgeries (68.4%), whereas non-oncologic elective surgeries were performed in 28.1% of the centers, ranging from 8.5% in high-risk to 45.1% in low-risk countries. Among the high risk countries, centers that continue oncologic elective surgeries varied from 48.3% in the USA to >80% in Italy and France. Centers that avoided laparoscopic surgery were less than 30% across countries in each risk category, except for UK (64.3%) and Turkey (51.7%). The use of dedicated Personal Protective Equipment (PPE) and the use of smoke-aspiration devices during laparoscopic surgery were proportional to the country risk categories and centers' caseloads. Over 30% of the centers in high and intermediate risk countries organized hospital team rotation, but 

Every patient is isolated until proved COVID-19 negative 101 ( Country-H -High risk country, Country-I -Intermediate risk country, Country-L -Low risk country, PPE -personal protective equipment *Percentages do not add up to 100 because of the multiple choice options.

VIEWPOINTS RESEARCH THEME 1:

the proportion per each country varied from 17.5% (Italy) to 69% (Turkey). Overall, 71.8% of the participants reported always wearing a medical mask in the hospital, but the proportion varied across the countries from 0% in the Netherlands, 21.4% in UK to >95% in Italy, France and China. Among PPEs, FFP2/FFP3 masks and eye protections were less available similarly across the countries.

Testing policies by countries' risk group, country, and centers' COVID-19 caseloads are summarized in in Table 5 , Table 6 and Table 7 . The majority (71.9%) of local guidelines recommended preoperative testing based on symptoms or suspicious radiologic findings. Local guidelines recommended testing every surgical patient in less than 20% of the centers. Routine screening by chest-Computer Tomography (CT) scan was used in only 22.8% of the overall centers, and the rates varied among the countries from 87.9% in China to 7.3% in the USA. Testing policies for staff members were also based on symptoms or risk contact in majority of the centers. Polimerase Chain Reaction (PCR) test without antibody testing was used in most of the countries, whereas nearly 30% of surgeons did not know which type of laboratory testing was used at their centers. The wait time to get test results was more than 1 day in 34.7% of the centers.

In-hospital COVID-19 infection by countries' risk group, country, and centers' COVID-19 caseloads are summarized in Table 5 , Table 6 and Table 7 . Overall, in-hospital COVID-19 infection was reported in 31.5% of the overall centers, and the rate was highest in the high risk countries (53.6%), but some 

In this large international survey involving 936 centers from 71 countries, we revealed the current global VIEWPOINTS RESEARCH THEME 1: Country-H -High risk country, Country-I -Intermediate risk country, Country-L -Low risk country, CT -computed tomography, PCR -polymerase chain reaction *Percentages do not add up to 100 because of the multiple choice questions. †The sum was the number of the respondents who answered "yes" in the question "Experienced in-hospital COVID-19 infection." VIEWPOINTS RESEARCH THEME 1: COVID-19 PANDEMIC 31 (3.8) 0 (0.0) 11 (6.2) 10 (6.6) 2 (0.9) 8 (3.5) 0.01 CT -computed tomography, PCR -polymerase chain reaction *Percentages do not add up to 100 because of the multiple choice questions. Data were analyzed in centers that provided †The sum was the number of the respondents who answered "yes" in the question "Experienced in-hospital COVID-19 infection".

situation of surgical practice including COVID-19 screening, preventive measures and in-hospital infection under the COVID-19 pandemic in early April 2020. To our knowledge, this is one of the largest international survey studies on COVID-19 in the field of surgery. The survey revealed two major findings. First, significant rates of centers had experienced in-hospital COVID-19 infection (31.5%) worldwide, and the majority of these centers failed to trace it or reported the infection originating from asymptomatic patients/staff members. The rates of in-hospital COVID-19 infection reached 53.6% in high risk counties and 84.4% in centers with >100 COVID-19 case load. Second, there were remarkable discrepancies among countries regarding the preoperative screening policies and perioperative preventive measures. We can conclude that under the current screening policies, COVID-19 patients impose problems with non-negligible frequency in surgical practice that may trigger hospital outbreaks, particularly in severely affected countries/institutions. VIEWPOINTS RESEARCH THEME 1:

Since the early phase of COVID-19 pandemic, preventive measures and screening policies worldwide focused on symptomatic patients, mainly based on previous experience with the influenza virus and Corona Virus 1 Severe Acute Respiratory Syndrome (SARS-CoV-1). Our study was compatible with these findings, and confirmed wide prevalence of the initial symptom-based preoperative testing policies which may have missed the asymptomatic cases: less than 20% of local guidelines worldwide tested every surgical patient with huge variations among countries. Such limited use of preoperative testing may also be related to a worldwide shortage of testing capacity and to >1 day waiting periods for test results as reported from at least 34.5% of the centers.

Although we have no direct evidence on the benefit of universal testing for surgical patients, recent emerging evidence brought the international and local surgical guidelines to recommend preoperative testing when available and practical [25] [26] [27] [28] [29] [30] . SARS-CoV-2 viral loads peak 5 days earlier than SARS-CoV-1, and is similarly detected in asymptomatic and symptomatic patients [34] [35] [36] . These traits of SARS-Cov-2 make asymptomatic patients more likely to transmit the disease than in the previous epidemics [37] [38] [39] . In hospital settings, a study from China reported a higher prevalence of asymptomatic COVID-19 infection in hospitalized patients (5.8%) compared to the community (1.2%), [40] and asymptomatic hospitalized patients were frequently reported as a source of in-hospital outbreaks [41] . In this study, local guidelines in the majority of the centers recommended testing based on symptoms or suspicious radiologic findings. Such testing policies may be challenged by the fact that over 30% of the centers worldwide experienced in-hospital COVID-19 infection, and almost 60% of those centers failed to trace it or reported originating from asymptomatic carriers. The proportion of centers with in-hospital COVID-19 infection was particularly high in severely affected countries/centers. In light of these findings, infection-control strategies focused solely on symptomatic patients may not be sufficient in surgical patients, particularly in highly affected countries/centers. A prospective universal testing program for surgical patients is warranted to clarify the prevalence of asymptomatic carriers, its potential impact on hospital outbreaks and the cost-benefit balance of the testing.

Another approach to deal with asymptomatic COVID-19 patients is the strict use of PPE and infection control measures. In this study, the universal use of dedicated PPE was proportional to the countries' risk categories and centers' caseloads, reaching 53.9% in the high risk countries and 71.9% in the highest caseload centers. This data implies surgeons' high concern and awareness of asymptomatic COVID-19 patients in the highly-affected countries/centers. Unfortunately, the study also disclosed insufficient availability of the PPE across the countries, particularly Filter Face Piece2 (FFP)/FFP3 masks and eye protections. Large disparities existed in the availability of the PPE across the countries. Surgeons must consider the local testing capability as well as PPE availability to decide the best protective measures under the current risk of asymptomatic COVID-19 patients.

Policies on wearing a mask for health care workers have been debated. The WHO guidelines recommend that health care workers should wear a medical mask when entering a room where patients with suspected or confirmed COVID-19 are admitted [42] . Although 71.8% of the participants in this study reported that they always wore a mask in the hospital, the rates were not linearly correlated with countries' risk category or centers' caseload but varied significantly across the countries from 0% to >95%, which reflects the lack of international consensus and perhaps cultural differences on this subject. In contrast to mask policies, the use of dedicated PPE was linearly correlated with the country risk categories and centers' caseloads. Interestingly, surgeons from UK reported the highest use of dedicated PPE in operation theatres (71.4%) but the lowest use of masks in hospital wards (21.4%) among the high risk countries. Further, our data showed that resource shortage was almost comparable in high caseload centers or high risk countries compared to the others. These findings suggest the use of PPE was dependent not only on supply but institutional or surgeons' policies.

In this study, countries were classified into the 3 risk categories by the number of cumulative deaths in light of the epidemiological situations on April 8, 2020 as described in the Methods. Although there is no consensus about what is the best index for the countries' pandemic status, this classification might be challenged as the number of deaths is not only dependent on the pandemic status but also on the population size and different definitions of the COVID-19-related deaths among the countries. Acknowledging these limitations, it is noteworthy that there were clear consistency between the results analyzed by the countries' risk category and those analyzed by the centers' COVID-19 caseload. For instance, centers with higher caseload (>100) adopted overall more preventive policies than lower caseload centers, including universal testing (in 100% of high caseload centers), routine testing of hospital staff and use of dedicated PPE in operation theatres. Similar trends were observed between these variables and the country risk VIEWPOINTS RESEARCH THEME 1: COVID-19 PANDEMIC category. The matching results between the two different risk categories (ie, countries' risk category and centers' caseloads) support the robustness of our analysis and results.

The strengths of this survey include large numbers and internationality of respondents and short period of recruitment to capture the current practice under rapid developments of COVID-19 crisis. However, this survey is subject to inherent systematic biases caused by unintended selection of centers at distribution, unequal number of centers per country and uneven geographical coverage. Only six countries (Italy, Spain, USA, China, Japan and Russia) were responsible for 62.2% of the participants, and the results may over-represent the situations in these countries. The response rate for the survey cannot be provided due to unlimited distribution through social media and academic societies, and the profiles or representativeness of the centers cannot be evaluated or compared between those did and did not respond to the survey. Voluntary participation of the survey may have resulted in recruiting respondents who have high interests in this topic and led to overestimation of the frequency and clinical impact of COVID-19 patients in surgical practice (a voluntary response bias). Acknowledging these limitations, this study tried to minimize the effect of such biases and obtain clinically meaningful results by collecting a large sample size and stratifying the data by countries' death number and centers' caseloads. We believe this survey does reflect current surgical practices, which highlights the emerging problems caused by COVID-19 patients.

In conclusion, this large international survey captured the global surgical practice under the COVID-19 pandemic and highlighted the insufficient preoperative screening of COVID-19 in the current surgical practice. We strongly believe that in the coming phase of pandemic, during which many medical centers will resume elective surgeries, a call for action in surgical departments is needed in global plans for infection control. More intensive screening programs will be necessary to prevent new potentially catastrophic outbreaks of infection in hospitals.

Enver Reyhan

Francesco Menegon Tasselli

Granila Vasil; Graziano Palmisano

Guillermo Berrones Steingel

Hasani Ariola

Hideki Ishikawa

Hideyuki Ishida

Hilmican Ulman; Hirofumi Kon; Hirofumi Ota; Hiroki Akamatsu; Hiroshi Tamagawa; Hirotaka Shoji

Ichiro Takemasa; Imerio Angriman; Ionut Negoi; Irina Volkova

Kei Ishimaru; Kei Kimura

Jenji Yamada; Kenta Tanakura

Koya Hida; Kozo Kataoka; Kumiko Hongo

Laura Lorenzon; Laura Muiños Ruano

Makoto Nagashima

Matteo Zuin; Mauricio Zuluaga; Maurizio Cervellera; Maurizio Cesari; Maurizio Zizzo; Mauro Garino

Milou Martens; Minako Kobayashi; Mingyang Ren

Muhammed Ikbal Akin; Munazza Laraibe; Murat Derebey

Mutsumi Fukunaga

Nattawut Keeratibharat; Nicola de Angelis

Nicolò Ramino; Nicolò Falco

Paola De Nardi; Patricia Tejedor

Piero Giustacchini; Pietro Anoldo; Pilar Concejo; Pin Cao

Raquel Leon Ledesma; Rategov Ruslan

Rocío González López; Rodrigo Oliva Perez; Roel Hompes

Sara Ingallinella

Satoshi Ikeda

Shigenori Homma; Shingo Tsujinaka; Shinichi Yoshioka; Shinichiro Mori; Shirish Tewari

Sho Horiuchi; Shuichiro Matoba; Shunji Morita; Sibel Yaman; Silvia Vigna; Silvio Testa; Simon Ng

Siyar Ersoz; Sofija Pejkova; Soliman Altarifi; Songbing He; Songphol Malakorn; Sosef Meindert; Sosuke Sumikawa

Stéphanie Breukink; Suk-Hwan Lee; Taishi Hata; Takahisa Ishikawa

Teruyuki Usub; Tetsuhiro Tsuruma; Tetsuichiro Shimizu; Tihomir Georgiev Hristov; Ting Van Loon

Tommaso Maria Manzia; Tomomichi Kiyomatsu; Tomonari Katayama; Tomonori Akagi; Tsunekazu Mizushima; Uemura Kazuhito

Valentina Sosa Rodríguez; Valentina Testa; Valeria Tonini

Vincenzo Papagni; Vincenzo Vento; Vincent Frering

Xinxin Wang; Xuanhua Yang; Xuelei Zhang; Ya'nan Zhen

Yusuke Kinugasa; Zacaria Sow; Zeeshan Razzaq; Zejun Wang

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering

At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy: Changing Perspectives on Preparation and Mitigation. NEJM Catalyst

How COVID-19 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond Infection

Gastrointestinal cancer surgery and enhanced recovery after surgery (ERAS) during COVID-19 outbreak

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths

Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV and implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study

Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19

COVID-19 Outbreak and Surgical Practice [Publish Ahead of Print

COVID-19 Pneumonia in Asymptomatic Trauma Patients; Report of 8 Cases

Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. Eclinical Medicine

Immune function after major surgical interventions: the effect of postoperative pain treatment

Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

COVID-19 Acoi guidelines

General recommendations of urgent surgical care in the context of the COVID-19 pandemic (SARS COV-2)

American College of Surgeon. Local resuption of elective surgery guidance

Update of intercollegiate general surgery guidance on COVID-19

Recommendation for surgical response during COVID-19

Impact of Asymptomatic COVID-19 Patients in Global Surgical Practice during the COVID-19 Pandemic

Improving the quality of web surveys: the checklist for reporting results of internet e-surveys (CHERRIES)

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Virological assessment of hospitalized patients with COVID-2019

SARS-CoV-2 Viral load in upper respiratory specimens of infected patients

Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome

Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community

Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19

The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou

Asymptomatic COVID-19 infection in a patient evaluated for ureteric colic: Radiological findings and impact on management

Advice on the use of masks in the community during home care and in the healthcare settings in the context of the novel coronavirus outbreak

We acknowledge all health-care workers involved in the diagnosis and treatment of COVID-19 patients worldwide. We would like to thank all the collaborators of "S-COVID Collaborative Group" (listed in a separate sheet) for contribution to the study; the surgical societies ( 

The study was registered with an analysis plan on ClinicalTrials.gov (NCT04344197). 

The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.